GALT基因突变致半乳糖血症1例并文献复习

Galactosemia caused by GALT gene mutation:A case report and literature review[J]. Chinese Journal of Child Health Care. 2024, 32(1): 113-116 https://doi.org/10.11852/zgetbjzz2022-1325

中图分类号： R589

参考文献

[1] Bosch AM. Classical galactosaemia revisited[J]. J Inherit Metab Dis, 2006, 29(4): 516-525.
[2] Li L, Ma L, Sun M, et al. High-throughput sequencing reveals the loss-of-function mutations in GALT cause recessive classical galactosemia[J]. Front Pediatr, 2020, 8:443.
[3] 孙嫱, 孟群, 刘小荣. 以大量蛋白尿起病的半乳糖血症1例[J]. 中华实用儿科临床杂志, 2020, 35(17): 1355-1357.
Sun Q, Meng Q, Liu XR. Case report of galactosemia with heavy proteinuria[J]. Chin J Appli Clin Pediatr, 2020, 35(17): 1355-1357.(in Chinese)
[4] 刘攀, 陆怡, 谢新宝, 等. 经典型半乳糖血症4例[J]. 中华肝脏病杂志, 2020, 28(1): 77-79.
Liu P, Lu Y, Xie XB,et al. Classical form of galactosemia: 4 cases[J]. Chin J Hepatol,2020, 28(1): 77-79.(in Chinese)
[5] 郭红梅, 郑必霞, 金玉. 以慢性腹泻为首发的GALT基因新突变经典半乳糖血症1例[J]. 中华实用儿科临床杂志, 2018, 33(7): 546-547.
Guo HM, Zheng BX, Jin Y. One case of classic galactosemia with a novel GALT mutation and chronic diarrhea as initial clinical manifestation[J]. Chin J Appli Clin Pediatr,2018, 33(7): 546-547.(in Chinese)
[6] 张海燕, 陈栋, 刘晨, 等. 两例新生儿经典型半乳糖血症的基因突变分析[J]. 中华医学遗传学杂志, 2018, 35(2): 248-252.
Zhang HY, Chen D, Liu C,et al. Diagnosis of two neonates with galactosemia by using next generation sequencing[J]. Chin J Med Genet,2018, 35(2): 248-252.(in Chinese)
[7] 王宇阳, 刘哲伟, 常会波, 等. 半乳糖血症患儿半乳糖-1-磷酸尿苷酰转移酶基因突变的鉴定与分析[J]. 中华实用儿科临床杂志, 2013, 28(8): 603-605.
Wang YY, Liu ZW, Chang HB, et al.phosphate uridyltransferase gene mutations in children with galactosemia[J]. Chin J Appl Clini Pediatr,2013, 28(8): 603-605.(in Chinese)
[8] 李晋蓉, 虞瑞欣, 胡若兰, 等. 经典半乳糖血症伴语言发育落后一例[J]. 华西医学, 2021,36(6): 838-840.
Li JR, Yu RX, Hu RL, et al. One case of classical galactosemia with delayed language development[J]. West China Medical Journal,2021, 36(6): 838-840.(in Chinese)
[9] Waisbren SE, Tran C, Demirbas D, et al. Transient developmental delays in infants with Duarte-2 variant galactosemia[J]. Mol Genet Metab, 2021, 134(1-2): 132-138.
[10] Succoio M, Sacchettini R, Rossi A, et al. Galactosemia: Biochemistry, molecular genetics, newborn screening, and treatment[J]. Biomolecules,2022,12(7):968.
[11] Rokaite· R, Traberg R, Dženkaitis M, et al. Two lithuanian cases of classical galactosemia with a literature review: A novel GALT gene mutation identified [J]. Medicina (Kaunas),2020,56(11):559.
[12] Nguyen TT, Le QT, Hoang DT,et al. Massively parallel sequencing uncovered disease-associated variant spectra of glucose-6-phosphate dehydrogenase deficiency, phenylketonuria and galactosemia in Vietnamese pregnant women [J]. Mol Genet Genomic Med,2022,10(7):e1959.
[13] Verdino A, D'Urso G, Tammone C, et al. Analysis of the structure-function-dynamics relationships of GALT enzyme and of its pathogenic mutant p.Q188R: A molecular dynamics simulation study in different experimental conditions[J]. Molecules, 2021, 26(19): 5941.
[14] Coelho AI, Rubio-Gozalbo ME, Vicente JB, et al. Sweet and sour: An update on classic galactosemia[J]. J Inherit Metab Dis, 2017, 40(3): 325-342.
[15] Ohlsson A, Hunt M, Wedell A, et al. Heterogeneity of disease-causing variants in the Swedish galactosemia population: Identification of 16 novel GALT variants[J]. J Inherit Metab Dis, 2019, 42(5): 1008-1018.
[16] Jezela-Stanek A, Bauer A, Wertheim-Tysarowska K,et al. The genetic basis of classical galactosaemia in Polish patients[J]. Orphanet J Rare Dis,2021,16(1):239.
[17] Suzuki M, West C, Beutler E. Large-scale molecular screening for galactosemia alleles in a pan-ethnic population[J]. Hum Genet, 2001, 109(2): 210-215.
[18] Kumar SU, Kumar DT, Siva R,et al. An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia[J]. Comput Biol Med, 2020,117:103583.
[19] Choi R, Jo KI, Ko DH,et al. Novel GALT variations and mutation spectrum in the Korean population with decreased galactose-1-phosphate uridyltransferase activity[J]. BMC Med Genet,2014,15:94.
[20] Coss KP, Doran PP, Owoeye C, et al. Classical galactosaemia in Ireland:Incidence, complications and outcomes of treatment[J]. J Inherit Metab Dis, 2013, 36(1): 21-27.
[21] Rubio-Gozalbo ME, Haskovic M, Bosch AM,et al. The natural history of classic galactosemia: Lessons from the GalNet registry[J]. Orphanet J Rare Dis,2019,14(1):86.
[22] Delnoy B, Coelho AI, Rubio-Gozalbo ME. Current and future treatments for classic galactosemia[J]. J Pers Med,2021,11(2):75.
[23] Welling L, Bernstein LE, Berry GT, et al. International clinical guideline for the management of classical galactosemia:Diagnosis, treatment, and follow-up[J]. J Inherit Metab Dis, 2017, 40(2): 171-176.